NASDAQ:ASTH Astrana Health (ASTH) Stock Price, News & Analysis $30.60 -0.80 (-2.55%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$30.58 -0.02 (-0.05%) As of 04/25/2025 04:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Astrana Health Stock (NASDAQ:ASTH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Astrana Health alerts:Sign Up Key Stats Today's Range$30.13▼$31.1650-Day Range$25.38▼$39.1352-Week Range$23.12▼$63.20Volume206,961 shsAverage Volume277,952 shsMarket Capitalization$1.53 billionP/E Ratio23.54Dividend YieldN/APrice Target$53.29Consensus RatingModerate Buy Company OverviewAstrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.Read More… Astrana Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks66th Percentile Overall ScoreASTH MarketRank™: Astrana Health scored higher than 66% of companies evaluated by MarketBeat, and ranked 237th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingAstrana Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 6 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageAstrana Health has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Astrana Health's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth22.61% Earnings GrowthEarnings for Astrana Health are expected to grow by 22.61% in the coming year, from $1.15 to $1.41 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Astrana Health is 23.54, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.70.Price to Earnings Ratio vs. SectorThe P/E ratio of Astrana Health is 23.54, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.43.Price to Earnings Growth RatioAstrana Health has a PEG Ratio of 1.37. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioAstrana Health has a P/B Ratio of 2.89. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Astrana Health's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted4.16% of the float of Astrana Health has been sold short.Short Interest Ratio / Days to CoverAstrana Health has a short interest ratio ("days to cover") of 4.7.Change versus previous monthShort interest in Astrana Health has recently increased by 6.16%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAstrana Health does not currently pay a dividend.Dividend GrowthAstrana Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted4.16% of the float of Astrana Health has been sold short.Short Interest Ratio / Days to CoverAstrana Health has a short interest ratio ("days to cover") of 4.7.Change versus previous monthShort interest in Astrana Health has recently increased by 6.16%, indicating that investor sentiment is decreasing significantly. News and Social Media2.1 / 5News Sentiment0.79 News SentimentAstrana Health has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Astrana Health this week, compared to 4 articles on an average week.Search InterestOnly 4 people have searched for ASTH on MarketBeat in the last 30 days. This is a decrease of -71% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Astrana Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 8.46% of the stock of Astrana Health is held by insiders.Percentage Held by Institutions52.77% of the stock of Astrana Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Astrana Health's insider trading history. Receive ASTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Astrana Health and its competitors with MarketBeat's FREE daily newsletter. Email Address ASTH Stock News HeadlinesTSS (NASDAQ:TSSI) and Astrana Health (NASDAQ:ASTH) Head to Head ComparisonApril 27 at 1:55 AM | americanbankingnews.comImplied Volatility Surging for Astrana (ASTH) Stock OptionsApril 26 at 11:25 AM | msn.comURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold. April 27, 2025 | Golden Portfolio (Ad)Astrana Health, Inc. to Participate in Upcoming Investor ConferenceApril 24 at 8:30 AM | prnewswire.comJefferies Keeps Their Buy Rating on Astrana Health (ASTH)April 24 at 3:00 AM | markets.businessinsider.comAstrana Health, Inc. (NASDAQ:ASTH) Receives Consensus Rating of "Moderate Buy" from AnalystsApril 21, 2025 | americanbankingnews.comAstrana Health (ASTH) Receives a Buy from Truist FinancialApril 20, 2025 | markets.businessinsider.comAstrana Health Inc. Common Stock (ASTH) After-HoursApril 20, 2025 | nasdaq.comSee More Headlines ASTH Stock Analysis - Frequently Asked Questions How have ASTH shares performed this year? Astrana Health's stock was trading at $31.53 on January 1st, 2025. Since then, ASTH shares have decreased by 2.9% and is now trading at $30.60. View the best growth stocks for 2025 here. How were Astrana Health's earnings last quarter? Astrana Health, Inc. (NASDAQ:ASTH) issued its quarterly earnings results on Thursday, February, 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.22 by $0.37. The company had revenue of $665.21 million for the quarter, compared to the consensus estimate of $617.24 million. Astrana Health had a net margin of 3.63% and a trailing twelve-month return on equity of 9.37%. Read the conference call transcript. Who are Astrana Health's major shareholders? Top institutional investors of Astrana Health include E. Ohman J or Asset Management AB (0.12%), State of Alaska Department of Revenue (0.05%), Illumine Investment Management LLC (0.04%) and Illinois Municipal Retirement Fund (0.04%). How do I buy shares of Astrana Health? Shares of ASTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Astrana Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Astrana Health investors own include Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX) and Visa (V). Company Calendar Last Earnings2/27/2025Today4/27/2025Next Earnings (Estimated)5/08/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Management consulting services Sub-IndustryBusiness Services Current SymbolNASDAQ:ASTH Previous SymbolNASDAQ:ASTH CIK1083446 Webwww.apollomed.net Phone626-282-0288Fax818-839-5190Employees1,900Year FoundedN/APrice Target and Rating Average Stock Price Target$53.29 High Stock Price Target$70.00 Low Stock Price Target$36.00 Potential Upside/Downside+74.1%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)$0.89 Trailing P/E Ratio23.54 Forward P/E Ratio26.61 P/E Growth1.37Net Income$60.72 million Net Margins3.63% Pretax Margin4.86% Return on Equity9.37% Return on Assets5.32% Debt Debt-to-Equity Ratio0.60 Current Ratio1.91 Quick Ratio1.91 Sales & Book Value Annual Sales$2.03 billion Price / Sales0.75 Cash Flow$1.17 per share Price / Cash Flow26.15 Book Value$10.58 per share Price / Book2.89Miscellaneous Outstanding Shares50,120,000Free Float51,494,000Market Cap$1.53 billion OptionableOptionable Beta1.04 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (NASDAQ:ASTH) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astrana Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astrana Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.